Esophageal Atresia Repair (Primary Anastomosis)
Treatment for Digestive congenital anomalies
Effectiveness
90%
Safety Score
45%
Clinical Trials
1
Participants
10K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
45
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate surgical correction, functional recovery 2-4 weeks
Treatment Duration
Acute (surgical), 2-4 weeks hospitalization, lifelong follow-up
Evidence Quality
MODERATEConfidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$200,000
Side Effect Mgmt:$20,000
Total Annual:$220,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
65
Outcome-Based Costs
Cost per Responder
$232,105
Cost per Remission
$259,412
Esophageal Atresia Repair (Primary Anastomosis) Outcomes
for Digestive congenital anomalies
Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+95%
Remission Rate
+85%
Common Side Effects
Anastomotic stricture
+35%
Gastroesophageal reflux (GERD)
+50%
Tracheomalacia
+15%
Recurrent tracheoesophageal fistula
+7%
Dysphagia/feeding difficulties
+30%
Infection
+10%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov